NCT07435324 2026-02-27A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell CarcinomaR-PharmPhase 3 Active not recruiting161 enrolled
NCT00956007 2026-01-06RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck CancerRadiation Therapy Oncology GroupPhase 3 Active not recruiting702 enrolled 35 charts
NCT04008030 2025-10-03CheckMate 8HWBristol-Myers SquibbPhase 3 Active not recruiting839 enrolled 22 charts 3 FDA
NCT04607421 2025-08-14A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal CancerPfizerPhase 3 Active not recruiting831 enrolled 5 FDA
NCT02999087 2025-05-07REACHGroupe Oncologie Radiotherapie Tete et CouPhase 3 Active not recruiting707 enrolled